Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amherst Baer Consultancy was a Canadian consulting and marketing services company rather than a drug developer or healthcare operating company. Publicly available records indicate it provided digital media, vendor management, marketing, and data analytics services, including work for public companies such as Lexston Life Sciences and Gratomic. The entity was incorporated federally in Canada in 2015 and later dissolved in 2022. There is no evidence that it operated a therapeutic pipeline, developed drug candidates, or maintained biotechnology, pharmaceutical, or healthcare products or services of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amherst Baer Consultancy.